Jabuticaba juice effects on blood glucose, insulin and antioxidants

Jabuticaba (Plinia jaboticaba) juice processed at high isostatic pressure and glycemic, insulinemic and antioxidant response in a pilot clinical trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

REBEC

Registry ID

RBR-5nxqy2

Enrollment

Unknown

Registered

2019-06-07

Start date

2018-06-07

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

16 healthy subjects were evaluated on two different occasions with a one-week interval between evaluations. The volunteers consumed jabuticaba nectar and placebo in a randomized order. The individuals

Dietary supplement

F01.829.458.205

Eligibility

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: healthy men and women aged 18-40 years; BMI 18-25 kg/m2.

Exclusion criteria

Exclusion criteria: allergy; hypersensitivity or intolerance to any foods/food ingredients; smokers; having a diagnosis of diabetes mellitus; hypertension or TAG; reported medical history of cardiovascular disease, cancer, liver, kidney or bowel disease; vegetarian or vegan diet; taking dietary supplements or receiving any drug treatment; pregnancy or breastfeeding.

Design outcomes

Primary

Measure	Time frame
It is expected to find differences in the areas under the curve (AUC) for glycemia and insulin after standard meal consumption. Intervention trial were designed to have 90% power to detect a clinical difference of 15% incremental AUC (IAUC) between the test and reference meal (a = 0.05). A total of 15 volunteers were required for the reference and test meals to achieve the aforementioned power and clinical difference. Thus, a minimum of 15 participants were recruited for each study because each participant was a control of themselves.	—

Measure

Time frame

It is expected to find differences in the areas under the curve (AUC) for glycemia and insulin after standard meal consumption. Intervention trial were designed to have 90% power to detect a clinical difference of 15% incremental AUC (IAUC) between the test and reference meal (a = 0.05). A total of 15 volunteers were required for the reference and test meals to achieve the aforementioned power and clinical difference. Thus, a minimum of 15 participants were recruited for each study because each participant was a control of themselves.

—

Secondary

Measure	Time frame
Secondary outcomes are not expected	—

Countries

Brazil

Contacts

Public ContactMarina;Marina Vilar Geraldi;Vilar Geraldi

Universidade Estadual de Campinas;Universidade Estadual de Campinas

marinavilar35@gmail.com;marinavilar35@gmail.com19988713274;19988713274

Outcome results

None listed

Source: REBEC (via WHO ICTRP)